Abstract
Heme oxygenase (HO)-1 is the inducible isoform of the first and rate-limiting enzyme of heme degradation. HO-1 has potent antioxidant and also anti-inflammatory functions, the underlying mechanisms of which are not well understood. Together with antioxidant carbon monoxide and biliverdin, HO produces reactive iron, which unambiguously connects this enzyme with the iron metabolism and its potential toxicity. A link between HO-1 and iron homeostasis has been demonstrated in HO-1 knockout mice, which develop major hemosiderosis in solid organs such as liver and kidney. Moreover, genetic HO-1 deficiency causes a chronic inflammatory condition in these animals. As the liver plays a crucial role for the bodys iron homeostasis (e.g. via secretion of the iron regulatory hormone hepcidin) and also for systemic inflammation, hepatic HO-1 may be important for the regulation of both systems. In particular, cell-specific functions of HO-1 in liver tissue macrophages (Kupffer cells) might be of major significance, because these cells play a key role in iron recycling during erythrophagocytosis and also in the control of hepatic and systemic inflammatory responses. This review discusses the current knowledge on interactions of HO-1 with iron metabolism in the context of systemic as well as hepatic inflammatory disorders. Recent advances in the understanding of the functional role of HO-1 in inflammatory liver diseases, namely viral hepatitis, alcoholic liver disease and non-alcoholic steatohepatitis are summarized. Finally, it is highlighted, how targeted modulation of HO-1 may provide specific protection in these inflammatory disorders.
Keywords: Antioxidant, heme oxygenase-1, hepcidin, inflammation, iron, liver, oxidative stress, isoform, anti-inflammatory, carbon monoxide, biliverdin, homeostasis, hemosiderosis, hormone hepcidin, Kupffer cells, viral hepatitis, alcoholic liver disease, non-alcoholic steatohepatitis, bilirubin (BR), reactive oxygen species (ROS), hemochromatosis, hepatocellular carcinoma (HCC), erythropoiesis, reticuloendothelial system (RES), iron regulatory protein (IRP)1, holoprotein, cytosolic aconitase, ferroportin (FRP), duodenal enterocytes, transferrin, alcoholic steatohepatitis, Hepcidin-dependent hypoferrem, Erythrophagocytosis, Kupffer cells (KCs), immunosensitized homologous, erythroid, toll-like receptor (TLR)-4, autophagy, phosphatidylinositol-3 kinase (PI3K)/Akt, aminoethyl-benzensulfonyl fluoride (AEBSF), microRNA-Mediated Strategies, hepatitis C virus, hepatoma cells, Alcoholic Liver Disease (ALD), pentoxyfyllin, Ginkgo biloba extract (GBE), aminotransferases, adiponectin, steatosis, steatohepatitis
Current Drug Targets
Title: Heme Oxygenase-1 and Iron in Liver Inflammation: A Complex Alliance
Volume: 11 Issue: 12
Author(s): Stephan Immenschuh, Eveline Baumgart-Vogt and Sebastian Mueller
Affiliation:
Keywords: Antioxidant, heme oxygenase-1, hepcidin, inflammation, iron, liver, oxidative stress, isoform, anti-inflammatory, carbon monoxide, biliverdin, homeostasis, hemosiderosis, hormone hepcidin, Kupffer cells, viral hepatitis, alcoholic liver disease, non-alcoholic steatohepatitis, bilirubin (BR), reactive oxygen species (ROS), hemochromatosis, hepatocellular carcinoma (HCC), erythropoiesis, reticuloendothelial system (RES), iron regulatory protein (IRP)1, holoprotein, cytosolic aconitase, ferroportin (FRP), duodenal enterocytes, transferrin, alcoholic steatohepatitis, Hepcidin-dependent hypoferrem, Erythrophagocytosis, Kupffer cells (KCs), immunosensitized homologous, erythroid, toll-like receptor (TLR)-4, autophagy, phosphatidylinositol-3 kinase (PI3K)/Akt, aminoethyl-benzensulfonyl fluoride (AEBSF), microRNA-Mediated Strategies, hepatitis C virus, hepatoma cells, Alcoholic Liver Disease (ALD), pentoxyfyllin, Ginkgo biloba extract (GBE), aminotransferases, adiponectin, steatosis, steatohepatitis
Abstract: Heme oxygenase (HO)-1 is the inducible isoform of the first and rate-limiting enzyme of heme degradation. HO-1 has potent antioxidant and also anti-inflammatory functions, the underlying mechanisms of which are not well understood. Together with antioxidant carbon monoxide and biliverdin, HO produces reactive iron, which unambiguously connects this enzyme with the iron metabolism and its potential toxicity. A link between HO-1 and iron homeostasis has been demonstrated in HO-1 knockout mice, which develop major hemosiderosis in solid organs such as liver and kidney. Moreover, genetic HO-1 deficiency causes a chronic inflammatory condition in these animals. As the liver plays a crucial role for the bodys iron homeostasis (e.g. via secretion of the iron regulatory hormone hepcidin) and also for systemic inflammation, hepatic HO-1 may be important for the regulation of both systems. In particular, cell-specific functions of HO-1 in liver tissue macrophages (Kupffer cells) might be of major significance, because these cells play a key role in iron recycling during erythrophagocytosis and also in the control of hepatic and systemic inflammatory responses. This review discusses the current knowledge on interactions of HO-1 with iron metabolism in the context of systemic as well as hepatic inflammatory disorders. Recent advances in the understanding of the functional role of HO-1 in inflammatory liver diseases, namely viral hepatitis, alcoholic liver disease and non-alcoholic steatohepatitis are summarized. Finally, it is highlighted, how targeted modulation of HO-1 may provide specific protection in these inflammatory disorders.
Export Options
About this article
Cite this article as:
Immenschuh Stephan, Baumgart-Vogt Eveline and Mueller Sebastian, Heme Oxygenase-1 and Iron in Liver Inflammation: A Complex Alliance, Current Drug Targets 2010; 11 (12) . https://dx.doi.org/10.2174/1389450111009011541
DOI https://dx.doi.org/10.2174/1389450111009011541 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modulation of Fatty Acids Oxidation in Heart Failure by Selective Pharmacological Inhibition of 3-Ketoacyl Coenzyme-A Thiolase
Current Clinical Pharmacology NF-κ B and Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
CNS & Neurological Disorders - Drug Targets Cyclophilin D as a Drug Target
Current Medicinal Chemistry Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
Current Neurovascular Research Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Current Stem Cell Research & Therapy Update in Pharmacological Management of Coronary No-Reflow Phenomenon
Cardiovascular & Hematological Agents in Medicinal Chemistry Interaction of Oligomeric Breast Cancer Resistant Protein (BCRP) with Adjudin: A Male Contraceptive with Anti-Cancer Activity
Current Molecular Pharmacology On the Cellular and Molecular Regulatory Transcriptional Mechanisms and Responsive Putative Pathways to Inflammatory Oxidative Stress Revisited: Current Immunological Breakthroughs and Views at a Glance
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier
Current Drug Metabolism Non-Alcoholic Steatohepatitis: New Insights from OMICS Studies
Current Pharmaceutical Biotechnology Troponin in Newborns and Pediatric Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry Serpin Regulation of Fibrinolytic System: Implications for Therapeutic Applications in Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer’s Disease
Current Drug Targets Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome
Current Molecular Pharmacology Membrane Ion Channels and Diabetes
Current Pharmaceutical Design Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes
Combinatorial Chemistry & High Throughput Screening Melatonin Attenuates Methamphetamine-Induced Neurotoxicity
Current Pharmaceutical Design The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies
Current Radiopharmaceuticals Nanocapsulated Ascorbic Acid in Combating Cerebral Ischemia Reperfusion- Induced Oxidative Injury in Rat Brain
Current Alzheimer Research